CVRx, Inc. 10-Q

Item 5. Other Information Adoption, Modification or Termination of Rule 10b5-1 Plans and Certain Other Trading Arrangements During the three months ended March 31, 2026, none of our directors or officers adopted, modified or terminated a “Rule 10 b 5 -1 trading arrangement” or “non-Rule 10 b 5 -1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except for certain sell-to-cover arrangements with our officers authorizing pre-arranged sales of shares of our common stock to satisfy tax withholding obligations we have arising exclusively from the vesting of RSUs and PSUs. The amount of shares to be sold to satisfy our withholding obligations under these arrangements is dependent on future events which cannot be known at this time, including the future trading price of our common stock. The expiration date relating to these arrangements is dependent on future events which cannot be known at this time, including the vesting date and any termination of service. Item 6. Exhibits EXHIBIT INDEX ​ ​ Exhibit No. ​ ​ ​ Description ​ 3.1 ​ Restated Certificate of Incorporation of CVRx, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 7, 2024) ​ ​ ​ 3.2 ​ Amended and Restated By-Laws of CVRx, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on July 7, 2021) ​ ​ ​ 10.1 ​ Second Amendment to Loan and Security Agreement, dated as of January 9, 2026, among the Company, Innovatus Life Sciences Lending Fund I, LP, as the collateral agent and a lender, and the other lenders from time to time party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 12, 2026) ​ ​ ​ 10.2 ​ Form of Performance Stock Unit Agreement (Executives – 2026-2027 Cumulative Revenue) pursuant to 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 3, 2026) ​ ​ ​ 31.1 † ​ Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ​ 31.2 † ​ Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ​ 32.1 † ​ Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ​ 32.2 † ​ Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ​ ​ ​ 101.INS † ​ Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document ​ 101.SCH † ​ Inline XBRL Taxonomy Extension Schema Document ​ 101.CAL † ​ Inline XBRL Taxonomy Extension Calculation Linkbase Document ​ 31 Table of Contents 101.DEF † ​ Inline XBRL Taxonomy Extension Definition Linkbase Document ​ 101.LAB † ​ Inline XBRL Taxonomy Extension Label Linkbase Document ​ 101.PRE † ​ Inline XBRL Taxonomy Extension Presentation Linkbase Document ​ ​ ​ 104 † ​ Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) † Filed herewith. 32 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto, duly authorized. Date: May 12, 2026 ​ ​ ​ ​ CVRX, INC. ​ ​ ​ ​ By: /s/ Kevin Hykes ​ Name: Kevin Hykes ​ Title: President and Chief Executive Officer ​ ​ (Principal Executive Officer) ​ ​ ​ ​ By: /s/ Jared Oasheim ​ Name: Jared Oasheim ​ Title: Chief Financial Officer ​ ​ (Principal Financial and Accounting Officer) ​ ​ ​ ​ ​ ​ ​ ​ 33